Santorini Scientific extend partnerships with internship at Imperial

May 25, 2022

Exploring TReg therapy to reduce post-transplant rejection

This summer, Santorini Scientific will be co-funding an internship with Imperial College London on Regulatory T-cell (TReg) therapy.


As the name suggests, TRegs are responsible for regulating immune responses therefore can be used to reduce autoimmune responses such as in cancer or, theoretically, rejection following a heart transplant.

30 May, 2024
Remodelling of the infarcted heart: piezoelectric multifunctional patch video release
30 May, 2024
Santorini Scientific Ltd and UWE Bristol announce new Accelerated Knowledge Transfer (AKT): Accelerating development of a multi-sensor, multi-culture cell model for evaluation of heart transplant rejection to enable personalised treatment
15 Jun, 2023
After a competitive process, project funding has been awarded by Innovate UK to Santorini Scientific for modelling rejection as a platform for future post-transplant therapies
25 May, 2023
Developing a model for analysing heart transplant patient data
13 Apr, 2023
SSL secured AHSN Network Grant in Collaboration with the University of The West of England
09 Feb, 2023
Non-invasive Diagnostics will reduce patients’ stress factors and infection risks 
21 Dec, 2022
SSL is looking to purchase a 3D Bioprinter and technical support. Can you help? If so, please download and reply to our tender.
Santorini Scientific secure ERDF funding for a new Cardiac Diagnostics Project
27 Jun, 2022
27 June 2022: ERDF funding under the KEEP+ programme to work with UWE
Exploring TReg therapy to reduce post-transplant rejection
25 May, 2022
25 May 2022: Exploring TReg therapy to reduce post-transplant rejection
Supporting trailblazing project at the University of Birmingham
17 May, 2022
17 May 2022: Post Graduate Taught (PGT) Knowledge Exchange Pathway (KEP)
More posts
Share by: